PubMed:12647426 JSONTXT

Annnotations TAB JSON ListView MergeView

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":136,"end":146},"obj":"HP_0000716"},{"id":"T2","span":{"begin":170,"end":180},"obj":"HP_0000716"},{"id":"T3","span":{"begin":195,"end":221},"obj":"HP_0007302"}],"text":"[Intravenous clomipramine for depressive disorders].\nWlewy dozylne klomipraminy u chorych z zaburzeniami depresyjnymi.\n51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disorder) were treated by the clomipramine intravenous infusions. The number of infusions varied from 5 to 21 (mostly 10-16). The median of maximal dose was 150 mg. There were significant clinical improvement measured by CGI. The therapy was well tolerated."}